At Lanmage, innovation is inspired from communication. Focused on clinical requirements, Lanmage listens to the voices of the medical community based on which Lanmage explores effective solutions and work on breakthroughs in integrating clinical and technical applications.
Lanmage invests 15% of its annual sales revenue into research and development, adheres to independent innovation, and maintains control over its core technologies. Every year, the company launches 3-6 new products, and each new product is designed with at least 10 patented technologies, to continuously establish new standards for medical image quality and efficiency.
Lanmage is a 'National Hi-tech Enterprise'. The company's core team is made up of experts from the first batch of technical engineers of medical imaging in China. Lanmage has created numerous records in the history of many medical devices in China, consistently broken the monopoly of foreign medical enterprises, filled the gaps in many domestic technologies and promoted the development of medical imaging technologies in China. Lanmage has created a benchmark in the industry in terms of independent research and development.
Lanmage works closely with the government in the research & development of new technologies for the future while continues to help build the medical imaging industry regulations and standards through engineering approaches.
of annual sales revenue spent on R&D
new products release
patents applied in each new product
staff with master degree or above
First ceiling-suspended DR with independent intellectual property rights in China
First fully automated ceiling-suspended DR with independent intellectual property rights in China
First mobile DR with independent intellectual property rights in China
First dynamic DR with independent intellectual property rights in China
First mammography DR for TOMO 3D and aspiration biopsy technologies with independent intellectual property rights in China
First batch of color ultrasound diagnostic systems in China